As of 2025-07-02, the Relative Valuation of Verrica Pharmaceuticals Inc (VRCA) is (13.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.60 USD, the upside of Verrica Pharmaceuticals Inc based on Relative Valuation is -2376.4%.
The range of the Relative Valuation is (13.96) - (13.03) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 18.3x | 18.0x |
| Forward P/E multiples | 19.6x - 22.2x | 20.4x |
| Fair Price | (13.96) - (13.03) | (13.68) |
| Upside | -2422.1% - -2267.8% | -2376.4% |
| Date | P/E |
| 2025-07-01 | -0.84 |
| 2025-06-30 | -0.74 |
| 2025-06-27 | -0.73 |
| 2025-06-26 | -0.82 |
| 2025-06-25 | -0.84 |
| 2025-06-24 | -0.84 |
| 2025-06-23 | -0.82 |
| 2025-06-20 | -0.82 |
| 2025-06-18 | -0.81 |
| 2025-06-17 | -0.90 |
| 2025-06-16 | -0.92 |
| 2025-06-13 | -0.87 |
| 2025-06-12 | -0.94 |
| 2025-06-11 | -0.87 |
| 2025-06-10 | -0.84 |
| 2025-06-09 | -0.86 |
| 2025-06-06 | -0.86 |
| 2025-06-05 | -0.82 |
| 2025-06-04 | -0.83 |
| 2025-06-03 | -0.74 |
| 2025-06-02 | -0.76 |
| 2025-05-30 | -0.69 |
| 2025-05-29 | -0.76 |
| 2025-05-28 | -0.76 |
| 2025-05-27 | -0.80 |
| 2025-05-23 | -0.86 |
| 2025-05-22 | -0.87 |
| 2025-05-21 | -0.89 |
| 2025-05-20 | -0.90 |
| 2025-05-19 | -0.90 |
| 2025-05-16 | -0.93 |
| 2025-05-15 | -0.90 |
| 2025-05-14 | -0.75 |
| 2025-05-13 | -0.77 |
| 2025-05-12 | -0.71 |
| 2025-05-09 | -0.62 |
| 2025-05-08 | -0.58 |
| 2025-05-07 | -0.57 |
| 2025-05-06 | -0.63 |
| 2025-05-05 | -0.62 |
| 2025-05-02 | -0.66 |
| 2025-05-01 | -0.66 |
| 2025-04-30 | -0.65 |
| 2025-04-29 | -0.64 |
| 2025-04-28 | -0.65 |
| 2025-04-25 | -0.69 |
| 2025-04-24 | -0.65 |
| 2025-04-23 | -0.64 |
| 2025-04-22 | -0.66 |
| 2025-04-21 | -0.65 |